LOS ANGELES and YANTAI, China, May 24, 2022 /PRNewswire/ — ImaginAb, Inc., a market leading global biotechnology company focused on developing next generation immuno-oncology imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce the signing of an exclusive…
